Teva Active Pharmaceutical Ingredients
Teva Active Pharmaceutical Ingredients (TAPI) is the API manufacturing and bioprocessing division of Teva Pharmaceutical Industries Ltd., supplying active pharmaceutical ingredients and bioprocessing services to pharmaceutical companies developing metabolic, fibrotic, and other disease treatments globally.
- Company typePrivate
- Founded1935
- Headquarters—
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Teva Active Pharmaceutical Ingredients firmographics
Firmographics- Name
- Teva Active Pharmaceutical Ingredients
- Legal name
- Teva Active Pharmaceutical Ingredients (TAPI)
- Website
- https://tapi.com
- Company type
- Private
- Founded year
- 1935
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Teva Active Pharmaceutical Ingredients (TAPI) is the API manufacturing and bioprocessing division of Teva Pharmaceutical Industries Ltd., supplying active pharmaceutical ingredients and bioprocessing services to pharmaceutical companies developing metabolic, fibrotic, and other disease treatments globally.
- Ownership category
- akta.pro rank
Teva Active Pharmaceutical Ingredients industry classification
Industry- Product category
- Active Pharmaceutical Ingredients (API) Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Small-Molecule API Commercial Manufacturing (HLAGAHAB)
- akta.pro secondary industries
- Small-Molecule API Process Development & Route Scouting (HLAGAHAA), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)
Keywords
Teva Active Pharmaceutical Ingredients business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel
Teva Active Pharmaceutical Ingredients product offering
Product offeringCore offering
TAPI manufactures and supplies Active Pharmaceutical Ingredients (APIs), including Resmetirom API, and provides bioprocessing services through its European facilities to support pharmaceutical partners in scaling production. It also engages in fixed-dose combination (FDC) development, combining APIs such as resmetirom with other compounds for clinical programs targeting metabolic and fibrotic diseases such as MASH.
Product overview
Teva Active Pharmaceutical Ingredients (TAPI) operates as a pharmaceutical API manufacturer offering Active Pharmaceutical Ingredients and bioprocessing services. The company provides resmetirom API through licensing agreements and offers bioprocessing capabilities in Europe to support pharmaceutical ingredient production. TAPI's offerings include fixed-dose combination development services, combining APIs such as resmetirom with other compounds for clinical development programs targeting metabolic and fibrotic diseases.
Differentiator
Problem solved
Functional benefit
Products and services
- Resmetirom API Active Pharmaceutical Ingredient (Resmetirom) licensed to Sagimet Biosciences for use in fixed-dose combination therapies combining resmetirom with Sagimet's denifanstat for Phase 3 trials targeting metabolic dysfunction-associated steatohepatitis (MASH).
- Bioprocessing Services Manufacturing and bioprocessing services delivered from TAPI's European facilities to enable pharmaceutical partners to scale up production of critical pharmaceutical ingredients and accelerate product launches.
- Fixed-Dose Combination (FDC) Development Program Fixed-dose combination development program combining Resmetirom API with Sagimet's denifanstat for Phase 3 clinical trials targeting metabolic dysfunction-associated steatohepatitis (MASH).
Companies that use Teva Active Pharmaceutical Ingredients
Customer profileSegments1 record
Ideal customer profiles1 record
Teva Active Pharmaceutical Ingredients technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Teva Active Pharmaceutical Ingredients partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Sagimet BiosciencesGlobal license agreement for innovative forms of Resmetirom API for Sagimet's fixed-dose combination (FDC) program. The collaboration focuses on combining resmetirom with Sagimet's denifanstat for potential use in Phase 3 trials targeting metabolic dysfunction-associated steatohepatitis (MASH). Clinical trials are underway with topline data expected by end of 2025.
- AntheiacoreStrategic partnership to enhance production of pharmaceutical ingredients using TAPI's bioprocessing capabilities in Europe. The partnership aims to increase the scale and speed of Antheia's product launches, supporting its mission to end drug shortages.
Recent moves3 records
Expansion highlights3 records
Teva Active Pharmaceutical Ingredients competitors and assessment
Company assessmentDirect peers
- Sandoz (Novartis API / industrial business): Sandoz operates one of the largest generic API and finished-dose manufacturing networks globally and is a direct peer to TAPI as a large-scale, vertically integrated API supplier serving global pharma customers.
- Aurobindo Pharma: Aurobindo is a major Indian-headquartered producer of generic APIs and finished dosage forms, competing directly with TAPI in the global small-molecule API supply market, particularly for high-volume generics.
- Dr. Reddy's Laboratories (API business): Dr. Reddy's operates a substantial global API manufacturing and supply business across small molecules, overlapping with TAPI's commercial API offering to pharmaceutical customers.
- Sun Pharma (including Taro API operations): Sun Pharma is a top-tier Indian generic manufacturer with significant in-house API production for its own formulations and third-party supply, directly comparable to TAPI's role within Teva.
- Cipla: Cipla is a major global manufacturer of generic APIs and finished formulations, with broad small-molecule API capabilities comparable to TAPI's portfolio.
- Siegfried Holding: Siegfried is a Swiss-headquartered CDMO specializing in small-molecule API manufacturing and finished drug products, directly comparable to TAPI in scale, geography (Europe), and offering.
- EuroAPI: EuroAPI is a European-based, large-scale API manufacturer spun out of Sanofi, with a similar focus on small-molecule APIs and European bioprocessing — directly comparable to TAPI's European manufacturing footprint.
- Cambrex (Thermo Fisher Scientific CDMO business): Cambrex, now part of Thermo Fisher's CDMO segment, is a leading small-molecule API manufacturer and is directly comparable to TAPI in commercial API offerings and global customer base.
- Divi's Laboratories: Divi's is a major Indian-headquartered manufacturer of APIs and intermediates, with scale and process-development capabilities directly comparable to TAPI's commercial API operations.
Broad incumbents
- Lonza Group: Lonza is a global CDMO incumbent offering a broader portfolio (including biologics and cell & gene) with a small-molecule API and bioprocessing offering that overlaps with TAPI's capabilities, particularly in Europe.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Teva Active Pharmaceutical Ingredients social profiles
Digital presenceTeva Active Pharmaceutical Ingredients financial estimates
Financial estimateRevenue estimate
Valuation estimate
Teva Active Pharmaceutical Ingredients leadership team
Management profileNumber of profiles
Teva Active Pharmaceutical Ingredients funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Teva Active Pharmaceutical Ingredients M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Teva Active Pharmaceutical Ingredients
What does Teva Active Pharmaceutical Ingredients do?
TAPI manufactures and supplies Active Pharmaceutical Ingredients (APIs), including Resmetirom API, and provides bioprocessing services through its European facilities to support pharmaceutical partners in scaling production. It also engages in fixed-dose combination (FDC) development, combining APIs such as resmetirom with other compounds for clinical programs targeting metabolic and fibrotic diseases such as MASH.
Is Teva Active Pharmaceutical Ingredients a public or private company?
Teva Active Pharmaceutical Ingredients is a private company. It is classified as corporate owned and is currently operating.
When was Teva Active Pharmaceutical Ingredients founded?
Teva Active Pharmaceutical Ingredients was founded in 1935. It employs 1,001 to 5,000 people.
Who are Teva Active Pharmaceutical Ingredients's main competitors?
Direct peers on record are Sandoz (Novartis API / industrial business), Aurobindo Pharma, Dr. Reddy's Laboratories (API business), Sun Pharma (including Taro API operations), Cipla, Siegfried Holding, EuroAPI, Cambrex (Thermo Fisher Scientific CDMO business) and Divi's Laboratories. Lonza Group is listed as a broad incumbent.
Does Teva Active Pharmaceutical Ingredients have an API?
No public API is recorded for Teva Active Pharmaceutical Ingredients.
What industry is Teva Active Pharmaceutical Ingredients in?
Teva Active Pharmaceutical Ingredients's product category is Active Pharmaceutical Ingredients (API) Manufacturing. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAGAHAA, Small-Molecule API Process Development & Route Scouting. Its NAICS code is 325411 and its SIC code is 2833.